All authors: Radboud university medical center, Nijmegen, the Netherlands.
J Clin Oncol. 2015 Sep 1;33(25):2763-71. doi: 10.1200/JCO.2013.54.9386. Epub 2015 Jul 13.
Early breast cancer survivors (BCSs) report high unmet care needs, and easily accessible care is not routinely available for this growing population. The Breast Cancer E-Health (BREATH) trial is a Web-based self-management intervention to support the psychological adjustment of women after primary treatment, by reducing distress and improving empowerment.
This multicenter, randomized, controlled, parallel-group trial evaluated whether care as usual (CAU) plus BREATH is superior to CAU alone. BREATH is delivered in sixteen fully automated weekly modules covering early survivorship issues. Two to 4 months post-treatment, BCSs were randomly assigned to receive CAU + BREATH (n = 70) or CAU alone (n = 80) using a stratified block design (ratio 1:1). Primary outcomes were distress (Symptom Checklist-90) and empowerment (Cancer Empowerment Questionnaire), assessed before random assignment (baseline, T0) and after 4 (T1), 6 (T2), and 10 months (T3) of follow-up. Statistical (analysis of covariance) and clinical effects (reliable change index) were tested in an intention-to-treat analysis (T0 to T1). Follow-up effects (T0 to T3) were assessed in assessment completers.
CAU + BREATH participants reported significantly less distress than CAU-alone participants (-7.79; 95% CI, -14.31 to -1.27; P = .02) with a small-to-medium effect size (d = 0.33), but empowerment was not affected (-1.71; 95% CI, 5.20 to -1.79; P = .34). More CAU + BREATH participants (39 of 70 [56%]; 95% CI, 44.1 to 66.8) than CAU-alone participants (32 of 80 [40%]; 95% CI, 30.0 to 51.0) showed clinically significant improvement (P = .03). This clinical effect was most prominent in low-distress BCSs. Secondary outcomes confirmed primary outcomes. There were no between-group differences in primary outcomes during follow-up.
Access to BREATH reduced distress among BCSs, but this effect was not sustained during follow-up.
早期乳腺癌幸存者(BCS)报告存在大量未满足的护理需求,而对于这一不断增长的群体,便捷的护理服务通常无法提供。Breast Cancer E-Health(BREATH)试验是一种基于网络的自我管理干预措施,旨在通过减轻困扰和提高赋权来支持女性在初级治疗后的心理调整。
这是一项多中心、随机、对照、平行组试验,评估了常规护理(CAU)加 BREATH 是否优于单独的 CAU。BREATH 通过十六个完全自动化的每周模块提供,涵盖早期生存问题。在治疗后 2 至 4 个月,BCSs 被随机分配接受 CAU+ BREATH(n = 70)或单独的 CAU(n = 80),使用分层块设计(比例为 1:1)。主要结局指标是困扰(症状清单 90)和赋权(癌症赋权问卷),在随机分配前(基线,T0)和 4(T1)、6(T2)和 10 个月(T3)随访时进行评估。在意向治疗分析(T0 至 T1)中测试了统计(协方差分析)和临床效果(可靠变化指数)。在评估完成者中评估了随访效果(T0 至 T3)。
与单独接受 CAU 的参与者相比,接受 CAU+ BREATH 的参与者报告的困扰明显减少(-7.79;95%置信区间,-14.31 至-1.27;P =.02),具有小到中等的效应大小(d = 0.33),但赋权没有受到影响(-1.71;95%置信区间,5.20 至-1.79;P =.34)。与单独接受 CAU 的参与者(32 名[40%];95%置信区间,30.0 至 51.0)相比,接受 CAU+ BREATH 的参与者(39 名[56%];95%置信区间,44.1 至 66.8)中有更多的人表现出临床显著改善(P =.03)。这种临床效果在低困扰 BCS 中最为明显。次要结局证实了主要结局。在随访期间,两组在主要结局方面没有差异。
获得 BREATH 降低了 BCS 的困扰,但这种效果在随访期间没有持续。